Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Patent
1986-06-25
1989-06-20
Schain, Howard E.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
424 89, 424101, 435212, 435215, 530350, 530362, 530363, 530364, 530369, 530380, 530381, 530382, 530383, 530384, 530385, 530389, 530373, 530395, 530399, 530410, 530808, 530809, A61K 3918, A61K 3929
Patent
active
048410233
ABSTRACT:
There is disclosed a process for rendering a labile protein-containing composition, substantially free of lipid-containing viruses without incurring substantial protein denaturation comprising contacting said composition with an effective amount of a fatty acid or a soluble ester, alcohol or a salt thereof for a sufficient period of time to inactivate virus contained therein.
REFERENCES:
patent: 3100737 (1963-08-01), Auerswald et al.
patent: 3497492 (1970-02-01), Buck et al.
patent: 3636196 (1972-01-01), Bauer et al.
patent: 3651211 (1972-03-01), Gilichriest et al.
patent: 3655871 (1972-04-01), Werner
patent: 3660234 (1972-05-01), Gray
patent: 3847737 (1974-11-01), Kanarelt
patent: 3926939 (1975-12-01), Ivanov et al.
patent: 3962421 (1976-06-01), Neurath
patent: 3983229 (1976-09-01), Relyveld
patent: 3992367 (1976-11-01), Plan et al.
patent: 4036952 (1977-07-01), Bauer et al.
patent: 4070454 (1978-01-01), Relyveld
patent: 4083958 (1978-04-01), Bryans
patent: 4156681 (1979-05-01), Schneider et al.
patent: 4177188 (1979-12-01), Hansen
patent: 4178126 (1979-12-01), Weep
patent: 4314997 (1982-02-01), Shanbrom
patent: 4315919 (1982-02-01), Shanbrom
patent: 4350707 (1982-09-01), Keith
patent: 4370264 (1983-01-01), Kotitschke et al.
patent: 4412985 (1983-11-01), Shanbrom
patent: 4424206 (1984-01-01), Ohmura et al.
patent: 4440679 (1984-04-01), Fernandes et al.
patent: 4481189 (1984-11-01), Prince
patent: 4540573 (1985-09-01), Neurath et al.
patent: 4581231 (1986-04-01), Purcell et al.
patent: 4591505 (1986-05-01), Prince
patent: 4613501 (1986-09-01), Horowitz
patent: 4720385 (1988-01-01), Lembach
patent: 4754019 (1988-06-01), Gion et al.
patent: 4764369 (1988-08-01), Neurath et al.
Hackh's Chemical Dictionary, 4th Ed. 1980, p. 261.
G. Norkrans et al., Vox Sang., 41, 129 (1981).
M. L. Fletcher, J. M. Trowell, J. Craske, K. Pavier, C. R. Rizza, Br. Med. J., 287, 1754 (1983).
M. J. Alter, Morbidity and Mortality Weekly Report; Surveillance Summaries, 32, 23SS (1983).
R. J. Gerety, D. L. Aronson, Transfusion, 22, 347 (1982).
E. Vilmer et al., Lancet, i, 753 (1984).
B. L. Evatt, D. P. Francis, M. F. T. McLane et al., Lancet, ii, 695 (1983).
J. Schupbach et al., Science, 224, 500 (1984).
M. G. Sarngadharan, M. Popovic, L. Bruch, J. Schupbach, R. C. Gallo, Science, 224, 506 (1984).
S. J. Feinstone, et al., Infect. Immun., 41, 816 (1983).
A. M. Prince et al., Vox Sang., 46, 36 (1984).
D. W. Bradley, J. E. Maynard, H. Popper et al., J. Infect. Dis., 148, 254 (1983).
R. S. Lane, Lancet, ii, 974 (1983).
A. M. L. Lever, A. D. B. Webster, D. Brown, H. C. Thomas, Lancet, i, 587 (1985).
H. D. Ochs, S. H. Fischer, F. S. Virant et al., Lancet, i, 404 (1985).
A. M. Prince, M. P. J. Piet, B. Horowitz, New England J. Med., 314, 186 (1986).
M. A. Wells et al., Transfusion, 26, 210 (1986).
N. Heimburger et al., Du Gelben Hefte, 20, 165, (1980).
M. Colombo et al., Lancet, i, 1 (1985).
F. E. Preston, C. R. M. Hay, M. S. Dewar, M. Greaves, D. R. Triger, Lancet, ii, 213 (1985).
P. B. A. Kernoff et al., Lancet, ii, 721 (1985).
P. M. Mannucci, M. Colombo, F. Rodeghiero, Lancet, ii, 1013 (1985).
F. B. Hollinger, G. Dolana, W. Thomas, F. Gyorkey, J. Infect. Dis., 150, 250 (1984).
R. H. Purcell et al., Hepatology, 5, 1091 (1985).
B. Horowitz, M. E. Wiebe, A. Lippin, J. Vandersande, M. H. Stryker, Transfusion, 25, 523 (1985).
B. Horowitz, M. E. Wiebe, A. Lippin, M. H. Stryker, Transfusion, 25, 516 (1985).
C. C. Strock, T. Francis, Jr., J. Exp. Med, 71, 661 (1940).
A. Kohn, J. Gitelman, M. Inbar, Arch. Virology, 66, 301 (1980).
W. Snipes, S. Person, A. Keith, J. Cupp, Science, 188, 64 (1975).
J. Sands, D. Auperin, W. Snipes, Antimicorbial Agents and Chemotherapy, 15 67 (1979).
J. C. Hierholzer, J. J. Karbara, J. Food Safety, 4, 1 (1982).
Toxic Substance List, H. E. Christensen (Ed.), 1974, p. 543.
Jefferson and Necheles, Proc. Soc. Exptl, Biol. Med., 68, 248 (1948).
New York Blood Center Inc.
Schain Howard E.
LandOfFree
Inactivation of viruses in labile protein-containing composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inactivation of viruses in labile protein-containing composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactivation of viruses in labile protein-containing composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-526018